We are excited to share a two-part series on direct-to-consumer advertising written by Lily Johns and Dr. Mezuk. The first article, titled “Placebo Effects and Direct-to-Consumer Advertising: How advertising shapes expectations around drug risks and benefits”, discusses direct-to-consumer advertising of prescription drugs in the context of the placebo effect. Building on this idea, the second article “Are Direct-to-Consumer Drug Ads Becoming Fair and Balanced?: How a new FDA rule may change pharmaceutical advertising”, discusses a recent FDA regulation on direct-to-consumer advertisements on TV/radio and the impacts it may have on the ads that we see everyday. Both articles are published on Dr. Mezuk’s Psychology Today blog “Ask an Epidemiologist”, which you can find here.